Nutritional and botanical interventions, including bitter herbs, omega-3 fatty acids and targeted nutrient balance offer evidence-based alternatives to GLP-1 drugs, as well as opportunities to support those patients already using GLP-1 medications in mitigating side effects and augmenting their results
Research indicates that diets rich in healthy fats, lean proteins, and low-glycemic carbohydrates can improve GLP-1 functionality, helping you achieve more sustainable weight loss results Studies show that incorporating low-glycemic foods can increase GLP-1 levels in the body, which directly impacts appetite control and boosts the weight loss effects of the medication
The SELECT trial establishing semaglutides 20% reduction in major adverse cardiovascular events has converted GLP-1 receptor agonists from single-indication obesity drugs into foundational chronic disease therapeutics demanding continuous prescription renewal
Step 1: Initial authorization for Wegovy UnitedHealthcare may approve initial authorization for Wegovy if you meet all of the following conditions : You are taking Wegovy either for weight loss or for cardiovascular risk reduction (if you also have heart disease )
The pharmacy label should tell you the BUD